Regulatory Approval
Search documents
Hoth Therapeutics(HOTH) - Prospectus
2024-04-11 20:15
As filed with the Securities and Exchange Commission April 11, 2024 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 HOTH THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Nevada 2834 82-1553794 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 590 Madison A ...
GRI Bio(GRI) - Prospectus
2023-12-21 22:13
As filed with the Securities and Exchange Commission on December 21, 2023. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GRI BIO, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 82-4369909 (I.R.S. Employer Identification Number) 2223 Avenida de la Playa ...
CNS Pharmaceuticals(CNSP) - Prospectus
2023-12-08 22:28
Table of Contents As filed with the Securities and Exchange Commission on December 8, 2023. Registration No. 333-___ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CNS Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Nevada 2834 82-2318545 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Nu ...
VALLON PHARMACEU(VLON) - Prospectus(update)
2023-12-04 21:24
As filed with the Securities and Exchange Commission on December 4, 2023. Registration No. 333-274972 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 ON FORM S-1 REGISTRATION STATEMENT (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 82-4369909 UNDER THE SECURITIES ACT OF 1933 GRI BIO, INC. (Exact name of registrant as specified in its charter) (I.R.S. Employ ...
Spyre Therapeutics(SYRE) - Prospectus(update)
2023-11-15 22:18
Table of Contents As filed with the Securities and Exchange Commission on November 15, 2023 Registration No. 333-273769 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Aeglea BioTherapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 46-4312787 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 221 Crescent Street Building 23, ...
Avenue Therapeutics(ATXI) - Prospectus(update)
2023-10-24 00:50
(State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) As filed with the Securities and Exchange Commission on October 23, 2023. Registration Statement No. 333-274562 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Avenue Therapeutics, Inc. (Exact name of registrant as specified in its charter) If this Form is filed to register additiona ...
Jyong Biotech Ltd(MENS) - Prospectus
2023-08-17 17:40
As filed with the Securities and Exchange Commission on August 17, 2023 Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM F-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ____________________________ Jyong Biotech Ltd. (Exact name of Registrant as specified in its charter) ____________________________ Not Applicable (Translation of Registrant's name into English) | Cayman Islands | 2834 | Not Applicable | | --- | --- | --- | | (State or o ...
180 Life Sciences (ATNF) - Prospectus(update)
2023-07-25 21:02
As filed with the U.S. Securities and Exchange Commission on July 25, 2023 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 180 Life Sciences Corp. (Exact name of registrant as specified in its charter) Delaware 2834 90-1890354 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification Number) 3000 El Camino Re ...
180 Life Sciences (ATNF) - Prospectus
2023-06-16 21:18
As filed with the U.S. Securities and Exchange Commission on June 16, 2023 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 180 Life Sciences Corp. (Exact name of registrant as specified in its charter) Delaware 2834 90-1890354 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification Number) Palo Alto, CA ...
Soligenix(SNGX) - Prospectus(update)
2023-05-04 21:30
Table of Contents As filed with the Securities and Exchange Commission on May 4, 2023. Registration No. 333-271049 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SOLIGENIX, INC. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) Delaware 2834 41-1505029 (I.R.S. Employer Identifi ...